Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Hisse Senetlerindeki Sıralama #2095
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Hisse Fiyatı
$142.09
Piyasa Değeri
$9.85B
Değişim (1 gün)
-0.39%
Değişim (1 yıl)
-56.81%
Ülke
US
Ticaret Insulet Corp. (PODD)

Kategori

Healthcare
Insulet Corp. (PODD) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $137.02 - 2026-10-01

Gün sonu en düşük fiyat: $15.32 - 2007-05-01
Insulet Corp. için hisse fiyatı geçmişi: 2007 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -28.61%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$100.56 -21.15%
US
$93.07 -2.88%
IE
$297.13 -21.76%
US
$44.47 -55.49%
US
$46.69 -17.17%
DE